Fact CheckerSign in

NCT07271823Active, not recruiting

Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer

Source: ClinicalTrials.gov · Last updated 9 Dec 2025

Brief summary (registry, in English)

This project aims to establish a single-center, prospective, observational clinical cohort for pancreatic cancer immunotherapy. It plans to enroll 100 patients with advanced pancreatic cancer, collecting tumor tissue sections, plasma, serum, and fecal samples. Through multi-omics analysis including proteomics, metabolomics, and microbiomics, the project will develop predictive models for immunotherapy response.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
26 Nov 2025
Start date
1 Sept 2024
Primary completion date
31 Dec 2026
Lead sponsor
Zhejiang Cancer Hospital
NCT number
NCT07271823

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 1 Sept 2024 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior receipt of immunotherapy or anti-angiogenic therapy.

Other illness

  • Active malignancy other than pancreatic cancer within the past 5 years or concurrently;

Who the study is looking for

  • Age 18 years or older;
  • Histologically or cytologically confirmed locally advanced or metastatic pancreatic ductal adenocarcinoma that is unresectable;
  • No prior systemic anticancer therapy;
  • At least one measurable lesion confirmed according to RECIST 1.1 criteria;
  • Receiving first-line treatment with an immunotherapy combined with chemotherapy regimen;
  • Signed informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Coordinator of this site? Confirm its status
ZhejiangChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.